Novavax (NASDAQ:NVAX), Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that Nuvaxovid™ (NVX-CoV2373) has been...
Vaccine developer Novavax Inc. (NASDAQ: NVAX) stock shot up 28% following its Q1 2023 earnings report. The company specializes in vaccines for infectious diseases, including COVID-19,...
Novavax (NASDAQ:NVAX), Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the Singapore Health Sciences...
An analyst from H.C. Wainwright maintained Novavax (NASDAQ: NVAX) at '' 'buy' and a price target of $35.00 from a prior price target of $110.00. Prior to this rating, Novavax had 2 buy...
Novavax (NVAX) Extends Gain, Now Up 47%Earlier Novavax rises 7% on strong guidance, plans to cut 25%...
Investing.com -- Stocks in focus in premarket trade on Monday, May 9th. Please refresh for updates. Palantir (NYSE:PLTR) stock rose 15.6% after the data analytics software maker said it...
Novavax (NASDAQ:NVAX) shares traded 6.5% higher in pre-market Tuesday after the pharma company announced a major restructuring process that is aimed at cutting costs. Novavax said it...
Investing.com - Novavax (NASDAQ: NVAX) reported first quarter EPS of $-3.41, better than the analyst estimate of $-3.42. Revenue for the quarter came in at $81M versus the consensus estimate...
Novavax (NASDAQ:NVAX), Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its COVID-Influenza Combination...
By Senad Karaahmetovic TD Cowen analysts downgraded Novavax (NASDAQ:NVAX) stock to Market Perform from Outperform, citing “significant uncertainties about the pending Gavi arbitration &...
A TD Cowen analyst downgraded Novavax (NASDAQ: NVAX) from Outperform to Market Perform with a price target of $10.00 from a prior price target of $55.00. Prior to this rating, Novavax had 3...
Novavax Inc's (NASDAQ: NVAX) CEO, newly appointed CEO John Jacobs, said the company would cut about $50 million in costs in Q1 of 2023 and plans further cuts. "We're looking at everything...
By Patrick Wingrove (Reuters) – Novavax Inc cut about $50 million in costs in the first quarter of 2023 and plans to slash more, Chief Executive John Jacobs said in an interview on...
Novavax (NASDAQ:NVAX) confirms that it maintains banking relationships with several large financial institutions and that it does not hold any deposits or securities or maintain any...
On February 28, 2023, Dr. Gregory M. Glenn, M.D. notified Novavax (NASDAQ:NVAX) of his decision to retire as President, Research and Development, effective as of March 31, 2023. The...
By Liz Moyer Investing.com -- Stocks edged lower on Wednesday to start a new month after ending lower for February. Here are the midday movers for March 1. Novavax Inc (NASDAQ:NVAX)...
By Liz Moyer Investing.com -- U.S stocks are wobbling to start a new month after ending February on a down note. At 9:51 ET (14:51 GMT), the Dow Jones Industrial Average was up 60 points or...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Wednesday, March 1st. Please refresh for updates. Kohl's (NYSE:KSS) stock fell 7.3% after the department store chain...
By Scott Kanowsky Investing.com -- Shares in Novavax Inc (NASDAQ:NVAX) shed over a fourth of their value in pre-market U.S. trading on Wednesday after the COVID-19 vaccine maker warned...
By Davit KirakosyanInvesting.com -- Here is your daily Pro Recap of the biggest earnings headlines you may have missed on InvestingPro since yesterday’s close. Start your free 7-day...
A look at the day ahead in U.S. and global markets from Mike DolanIf there were still doubts about a re-acceleration of the world economy into 2023, China's February business boom likely put...
Novavax (NVAX) has filed mixed shelf of:Common StockPreferred StockDebt SecuritiesWarrantsUnits
By Oliver Gray Investing.com - Dow futures were trading slightly lower during Tuesday's evening trade, after major indices closed out the month of February with significant losses, while...
After-Hours Movers: Novavax (NASDAQ:NVAX) 25% LOWER; {{erl-16770||reported Q4 EPS of ($2.28), $1.09 worse than the analyst estimate of ($1.19). Revenue for the quarter came in at $357...
Novavax (NASDAQ:NVAX) reported Q4 EPS of ($2.28), $1.09 worse than the analyst estimate of ($1.19). Revenue for the quarter came in at $357 million versus the consensus estimate of...
Investing.com - Novavax (NASDAQ: NVAX) reported fourth quarter EPS of $-2.28, $1.09 worse than the analyst estimate of $-1.19. Revenue for the quarter came in at $357M versus the consensus...
By Liz Moyer Investing.com -- U.S. stocks were rising in early trading as investors tried to shrug off last week's losses. At 9:47 ET (14:47 GMT), the Dow Jones Industrial Average was up 116...
By Liz Moyer Investing.com -- U.S. stocks slumped on Thursday but closed off their lows for the day as investors reacted to the Federal Reserve's higher for longer stance on interest...
By Liz Moyer Investing.com -- Stocks were down more than 900 points on Thursday a day after the Fed signaled interest rates will remain elevated for longer and could top 5% next year. Here...
By Senad Karaahmetovic Shares of Novavax (NASDAQ:NVAX) are trading about 20% lower Thursday, further highlighting the catastrophic year for the stock, which is down 88% year-to-date...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Thursday, December 15th. Please refresh for updates. Tesla (NASDAQ:TSLA) stock fell 1.6% after filings showed CEO Elon...
After-Hours Stock Movers: Core Scientific Inc (NASDAQ:CORZ) 60% HIGHER; adds to 70% intra-day gains as B. Riley Financial Inc (NASDAQ:RILY) proposed a debt restructuring to avoid...
Investing.com - Novavax reported on Tuesday third quarter {{erl-16770||earnings that missed analysts' forecasts and revenue that topped expectations. Novavax announced earnings per share...
Novavax (NVAX) reported Q3 EPS of ($2.15), $3.78 worse than the analyst estimate of $1.63. Revenue for the quarter came in at $735 million versus the consensus estimate of $623.9...
By Liz Moyer Investing.com -- U.S. stocks extended their losses, falling deeper into a bear market on fears of a global growth slowdown. Here are the midday movers for Sept. 27: Hertz...
By Liz Moyer Investing.com -- U.S. stocks fell on Thursday as investors continued to digest the Federal Reserve's latest policy statement. Here are the midday movers for Sept. 22: ...
By Senad Karaahmetovic Novavax (NASDAQ:NVAX) shares are down over 5% today after a JPMorgan analyst downgraded to Underweight from Neutral. The analyst also slashed the price target by...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Thursday, September 22nd. Please refresh for updates. Lennar (NYSE:LEN) stock fell 1.5% after the homebuilder...
By Peter Nurse Investing.com -- The main focus of the day will be the release of the latest U.S. consumer price data and the potential impact this has on Fed thinking. Elon Musk’s...
BBQ Holdings Inc (NASDAQ:BBQ) +46%; entered into a definitive merger agreement under which MTY would acquire all of the issued and outstanding common shares of BBQ Holdings for cash...
By Senad Karaahmetovic Shares of Novavax (NASDAQ:NVAX) crashed almost 33% in premarket Tuesday trading after the company cut its full-year revenue guidance. For the second quarter,...
By Peter Nurse Investing.com -- U.S. stocks are seen opening in a subdued fashion Tuesday, with investors awaiting more corporate earnings results as well as the release of a key...
By Oliver Gray Investing.com - U.S. stock futures were slightly higher during Monday’s evening deals, after major benchmark averages finished mixed during regular trading as market...
GoodRx Holdings, Inc. (GDRX) +34%; Revenue for the quarter came in at $191.8 million versus the consensus estimate of $185.36 million.Lemonade (LMND) +13%; reported Q2 EPS of ($1.10), $0.23...
Novavax (NASDAQ:NVAX) reported Q2 EPS of ($6.53), $12.03 worse than the analyst estimate of $5.50. Revenue for the quarter came in at $186 billion versus the consensus estimate of $1.02...
By Geoffrey Smith Investing.com -- U.S. stocks are set to open higher after the Democrats' long-awaited and much-diluted tax and spending bill finally cleared the Senate at the weekend. A...
By Vlad Schepkov It’s official! The U.S. Food and Drug Administration (FDA) has at last given its affirmative nod to what is now the 4th officially approved COVID-19 vaccine in the United...
By Liz Moyer Investing.com -- U.S. stocks wobbled on Wednesday after a higher-than-expected reading on June inflation. Here are the midday movers for July 13: Twitter Inc (NYSE:TWTR)...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
